Eli Lilly Pharma Company dropped Air Insulin (inhaled form) phase 3 clinical trials. Pfizer dropped its inhaled insulin “Exubera” in 2007 due to its potential side effects on lung function. Novo Nordisk halted its inhaled insulin droplets drug, AERx, in January. Eli Lilly conducted "Air Insulin" clinical trials in partnership with biotechnology company "Alkermes".         Even though Air Insulin had not shown any potential side effects in the clinical trials, Eli Lilly dropped this inhaler form due to lack of commercial viability, reluctance of doctors and potential regulation problems.     Diabetics’ hopes for inhaler form were finally ended with Eli Lilly’s decision. They need to depend on injection form for some more time.     But, Mankind is committed to continue its trials on Technosphere Insulin inhaler. Mankind is conducting phase 3 clinical trials on 2,050 patients. No significant side effects are reported till date.       Click here to know more about "Air Insulin".         … [Read more...]